Karsten Midtvedt

     

    Publications 2019

    Eide IA, Rashidi F, Lønning K, Oldereid NB, Reisæter AV, Åsberg A, Midtvedt K (2019)
    Contraceptive Choices and Counseling in Norwegian Female Renal Transplant Recipients
    Transplant Proc, 51 (2), 470-474
    DOI 10.1016/j.transproceed.2019.01.068, PubMed 30879570

    Gustavsen MT, Midtvedt K, Lønning K, Jacobsen T, Reisaeter AV, De Geest S, Andersen MH, Hartmann A, Åsberg A (2019)
    Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trial
    Transpl Int, 32 (6), 614-625
    DOI 10.1111/tri.13412, PubMed 30770608

    Halden TAS, Kvitne KE, Midtvedt K, Rajakumar L, Robertsen I, Brox J, Bollerslev J, Hartmann A, Åsberg A, Jenssen T (2019)
    Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus
    Diabetes Care, 42 (6), 1067-1074
    DOI 10.2337/dc19-0093, PubMed 30862658

    Haugen AJ, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2019)
    Long-term risk for kidney donors with hypertension at donation - a retrospective cohort study
    Transpl Int (in press)
    DOI 10.1111/tri.13443, PubMed 30983060

    Klaasen RA, Egeland EJ, Chan J, Midtvedt K, Svensson M, Bolstad N, Fellström B, Holdaas H, Åsberg A, Bergan S, Vethe NT, Warren DJ (2019)
    A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients
    Ther Drug Monit, 41 (1), 11-18
    DOI 10.1097/FTD.0000000000000580, PubMed 30633722

    Publications 2018

    Egeland EJ, Reisaeter AV, Robertsen I, Midtvedt K, Strøm EH, Holdaas H, Hartmann A, Åsberg A (2018)
    High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort study
    Transpl Int, 32 (3), 257-269
    DOI 10.1111/tri.13356, PubMed 30252957

    Egeland EJ, Størset E, Robertsen I, Hermann M, Midtvedt K, Gustavsen MT, Klaasen R, Bergan S, Hartmann A, Åsberg A (2018)
    The Authors' Reply
    Transplantation, 102 (1), e43-e44
    DOI 10.1097/TP.0000000000001961, PubMed 28957846

    Foss S, Nordheim E, Sørensen DW, Syversen TB, Midtvedt K, Åsberg A, Dahl T, Bakkan PA, Foss AE, Geiran OR, Fiane AE, Line PD (2018)
    First Scandinavian Protocol for Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion
    Transplant Direct, 4 (7), e366
    DOI 10.1097/TXD.0000000000000802, PubMed 30046656

    García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Reisaeter AV, Seron D (2018)
    Kidney allograft subclinical rejection modulates systemic inflammation measured by C-reactive protein at 1 year after transplantation
    Clin Transplant, 32 (3), e13196
    DOI 10.1111/ctr.13196, PubMed 29380890

    Heldal K, Midtvedt K, Hartmann A, Reisaeter AV, Heldal TF, Bergan S, Salvador CL, Åsberg A (2018)
    Estimated glomerular filtration rate in stable older kidney transplant recipients-are present algorithms valid? A national cross-sectional cohort study
    Transpl Int, 31 (6), 629-638
    DOI 10.1111/tri.13137, PubMed 29453878

    Klaasen RA, Bergan S, Bremer S, Daleq L, Andersen AM, Midtvedt K, Skauby MH, Vethe NT (2018)
    Longitudinal Study of Tacrolimus in Lymphocytes During the First Year After Kidney Transplantation
    Ther Drug Monit, 40 (5), 558-566
    DOI 10.1097/FTD.0000000000000539, PubMed 30086087

    Lønning K, Heldal K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisæter AV, Line PD, Hartmann A, Midtvedt K (2018)
    Improved Health-Related Quality of Life in Older Kidney Recipients 1 Year After Transplantation
    Transplant Direct, 4 (4), e351
    DOI 10.1097/TXD.0000000000000770, PubMed 29707622

    Lønning K, Midtvedt K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisaeter AV, Line PD, Hartmann A, Heldal K (2018)
    Changes in health-related quality of life in older candidates waiting for kidney transplantation
    Nephrology (Carlton), 23 (10), 948-956
    DOI 10.1111/nep.13117, PubMed 28734131

    Lønning K, Midtvedt K, Heldal K, Andersen MH (2018)
    Older kidney transplantation candidates' expectations of improvement in life and health following kidney transplantation: semistructured interviews with enlisted dialysis patients aged 65 years and older
    BMJ Open, 8 (6), e021275
    DOI 10.1136/bmjopen-2017-021275, PubMed 29934388

    Nordheim E, Horneland R, Aandahl EM, Grzyb K, Aabakken L, Paulsen V, Midtvedt K, Hartmann A, Jenssen T (2018)
    Pancreas transplant rejection episodes are not revealed by biopsies of the donor duodenum in a prospective study with paired biopsies
    Am J Transplant, 18 (5), 1256-1261
    DOI 10.1111/ajt.14658, PubMed 29316221

    Nordheim E, Olafsson Storrø M, Natvik AK, Birkeland Kro G, Midtvedt K, Varberg Reisaeter A, Hagness M, Fevang B, Pettersen FO (2018)
    Donor-derived strongyloidiasis after organ transplantation in Norway
    Transpl Infect Dis, 21 (1), e13008
    DOI 10.1111/tid.13008, PubMed 30295406

    Publications 2017

    Bremer S, Vethe NT, Skauby M, Kasbo M, Johansson ED, Midtvedt K, Bergan S (2017)
    NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation
    Br J Clin Pharmacol, 83 (11), 2494-2502
    DOI 10.1111/bcp.13367, PubMed 28686294

    Dahle DO, Grotmol T, Leivestad T, Hartmann A, Midtvedt K, Reisæter AV, Mjøen G, Pihlstrøm HK, Næss H, Holdaas H (2017)
    Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients
    Transplantation, 101 (10), 2599-2605
    DOI 10.1097/TP.0000000000001659, PubMed 28207636

    Egeland EJ, Robertsen I, Hermann M, Midtvedt K, Størset E, Gustavsen MT, Reisæter AV, Klaasen R, Bergan S, Holdaas H, Hartmann A, Åsberg A (2017)
    High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation
    Transplantation, 101 (8), e273-e279
    DOI 10.1097/TP.0000000000001796, PubMed 28452920

    García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV (2017)
    Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies
    Transplantation, 101 (6), 1410-1415
    DOI 10.1097/TP.0000000000001216, PubMed 27163535

    Heldal K, Hartmann A, Lønning K, Leivestad T, Reisæter AV, Line PD, Holdaas H, Midtvedt K (2017)
    Should patients older than 65 years be offered a second kidney transplant?
    BMC Nephrol, 18 (1), 13
    DOI 10.1186/s12882-016-0426-0, PubMed 28077080

    Hole K, Størset E, Olastuen A, Haslemo T, Kro GB, Midtvedt K, Åsberg A, Molden E (2017)
    Recovery of CYP3A Phenotype after Kidney Transplantation
    Drug Metab Dispos, 45 (12), 1260-1265
    DOI 10.1124/dmd.117.078030, PubMed 28928137

    Lindahl JP, Massey RJ, Hartmann A, Aakhus S, Endresen K, Günther A, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Øyen O, Jenssen T (2017)
    Cardiac Assessment of Patients With Type 1 Diabetes Median 10 Years After Successful Simultaneous Pancreas and Kidney Transplantation Compared With Living Donor Kidney Transplantation
    Transplantation, 101 (6), 1261-1267
    DOI 10.1097/TP.0000000000001274, PubMed 27467687

    Midtvedt K, Bergan S, Reisæter AV, Vikse BE, Åsberg A (2017)
    Exposure to Mycophenolate and Fatherhood
    Transplantation, 101 (7), e214-e217
    DOI 10.1097/TP.0000000000001747, PubMed 28346297

    Midtvedt K, Holdaas H, Bergan S, Åsberg A (2017)
    Costimulation Blockade: America First, Canada Second … What About Norway?
    Am J Transplant, 17 (8), 2230
    DOI 10.1111/ajt.14351, PubMed 28508535

    Midtvedt K, Åsberg A (2017)
    Mycophenolate Acid and Balancing the Risk for Male Allograft Recipients
    Transplantation, 101 (1), e39
    DOI 10.1097/TP.0000000000001509, PubMed 27748704

    Pihlstrøm HK, Gatti F, Hammarström C, Eide IA, Kasprzycka M, Wang J, Haraldsen G, Svensson MHS, Midtvedt K, Mjøen G, Dahle DO, Hartmann A, Holdaas H (2017)
    Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study
    Transpl Int, 30 (8), 827-840
    DOI 10.1111/tri.12973, PubMed 28436117

    Pippias M, Jager KJ, Caskey F, Casula A, Erlandsson H, Finne P, Heaf J, Heinze G, Hoitsma A, Kramar R, Lempinen M, Magaz A, Midtvedt K, Mumford LL, Pascual J, Prütz KG, Sørensen SS, Traynor JP, Massy ZA, Ravanan R, Stel VS (2017)
    Kidney transplant outcomes from older deceased donors: a paired kidney analysis by the European Renal Association-European Dialysis and Transplant Association Registry
    Transpl Int, 31 (7), 708-719
    DOI 10.1111/tri.13103, PubMed 29210108

    Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2017)
    The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation
    Br J Clin Pharmacol, 83 (7), 1457-1465
    DOI 10.1111/bcp.13248, PubMed 28146606

    Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2017)
    Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'
    Br J Clin Pharmacol, 83 (6), 1357-1358
    DOI 10.1111/bcp.13276, PubMed 28374426

    Torres IB, Reisaeter AV, Moreso F, Âsberg A, Vidal M, Garcia-Carro C, Midtvedt K, Reinholt FP, Scott H, Castellà E, Salcedo M, Dörje C, Sellarés J, Azancot MA, Perello M, Holdaas H, Serón D (2017)
    Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants
    Transpl Int, 30 (11), 1119-1131
    DOI 10.1111/tri.13002, PubMed 28667664

    Åsberg A, Robertsen I, Midtvedt K (2017)
    How to Report and Interpret Bioequivalence Data in Solid Organ Transplant Recipients
    Transplantation, 101 (11), e347
    DOI 10.1097/TP.0000000000001894, PubMed 28787310

    Publications 2016

    Dörje C, Reisaeter AV, Dahle DO, Mjøen G, Midtvedt K, Holdaas H, Flaa-Johnsen L, Syversveen T, Hartmann A, Jenssen T, Scott H, Reinholt FP (2016)
    Total inflammation in early protocol kidney graft biopsies does not predict progression of fibrosis at one year post-transplant
    Clin Transplant, 30 (7), 802-9
    DOI 10.1111/ctr.12753, PubMed 27101801

    Halden TA, Egeland EJ, Åsberg A, Hartmann A, Midtvedt K, Khiabani HZ, Holst JJ, Knop FK, Hornum M, Feldt-Rasmussen B, Jenssen T (2016)
    GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes
    Diabetes Care, 39 (4), 617-24
    DOI 10.2337/dc15-2383, PubMed 26908914

    Lønning K, Midtvedt K, Leivestad T, Reisæter AV, Line PD, Hartmann A, Heldal K (2016)
    Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
    Transplantation, 100 (12), 2705-2709
    DOI 10.1097/TP.0000000000001363, PubMed 27861296

    Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2016)
    Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
    Nephrol Dial Transplant, 31 (1), 170
    DOI 10.1093/ndt/gfv397, PubMed 26740671

    Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2016)
    Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance
    Br J Clin Pharmacol, 83 (6), 1350-1352
    DOI 10.1111/bcp.13188, PubMed 28008657

    Størset E, von Düring ME, Godang K, Bergan S, Midtvedt K, Åsberg A (2016)
    Prediction of Fat-Free Mass in Kidney Transplant Recipients
    Ther Drug Monit, 38 (4), 439-46
    DOI 10.1097/FTD.0000000000000305, PubMed 27019101

    Størset E, Åsberg A, Hartmann A, Reisaeter AV, Holdaas H, Skauby M, Bergan S, Midtvedt K (2016)
    Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience
    Nephrology (Carlton), 21 (10), 821-7
    DOI 10.1111/nep.12738, PubMed 26854648

    Publications 2015

    Dörje C, Mjøen G, Strøm EH, Holdaas H, Jenssen T, Øyen O, Akkök ÇA, Cvancarova M, Midtvedt K, Reisaeter AV (2015)
    One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts
    Clin Transplant, 29 (3), 268-76
    DOI 10.1111/ctr.12515, PubMed 25644963

    Lindahl JP, Hartmann A, Aakhus S, Endresen K, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Øyen O, Jenssen T (2015)
    Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation
    Diabetologia, 59 (4), 844-52
    DOI 10.1007/s00125-015-3853-8, PubMed 26713324

    Murbraech K, Massey R, Undset LH, Midtvedt K, Holdaas H, Aakhus S (2015)
    Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients--a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trial
    Clin Transplant, 29 (8), 678-84
    DOI 10.1111/ctr.12565, PubMed 25982053

    Robertsen I, Vethe NT, Midtvedt K, Falck P, Christensen H, Åsberg A (2015)
    Closer to the Site of Action: Everolimus Concentrations in Peripheral Blood Mononuclear Cells Correlate Well With Whole Blood Concentrations
    Ther Drug Monit, 37 (5), 675-80
    DOI 10.1097/FTD.0000000000000185, PubMed 25565673

    Robertsen I, Åsberg A, Ingerø AO, Vethe NT, Bremer S, Bergan S, Midtvedt K (2015)
    Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed
    Transplantation, 99 (3), 528-32
    DOI 10.1097/TP.0000000000000384, PubMed 25148382

    Størset E, Åsberg A, Skauby M, Neely M, Bergan S, Bremer S, Midtvedt K (2015)
    Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study
    Transplantation, 99 (10), 2158-66
    DOI 10.1097/TP.0000000000000708, PubMed 25886918

    Publications 2014

    Dörje C, Midtvedt K, Reisæter AV (2014)
    Analysis of predictive and preventive factors for de novo donor-specific antibodies in kidney transplant recipientsy--is nonadherence of importance?
    Transplantation, 98 (4), e31
    DOI 10.1097/TP.0000000000000330, PubMed 25243517

    Hirsch HH, Babel N, Comoli P, Friman V, Ginevri F, Jardine A, Lautenschlager I, Legendre C, Midtvedt K, Muñoz P, Randhawa P, Rinaldo CH, Wieszek A, ESCMID Study Group of Infection in Compromised Hosts (2014)
    European perspective on human polyomavirus infection, replication and disease in solid organ transplantation
    Clin Microbiol Infect, 20 Suppl 7, 74-88
    DOI 10.1111/1469-0691.12538, PubMed 24476010

    Lindahl JP, Reinholt FP, Eide IA, Hartmann A, Midtvedt K, Holdaas H, Dorg LT, Reine TM, Kolset SO, Horneland R, Øyen O, Brabrand K, Jenssen T (2014)
    In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone
    Diabetologia, 57 (11), 2357-65
    DOI 10.1007/s00125-014-3353-2, PubMed 25145544

    Lunde I, Bremer S, Midtvedt K, Mohebi B, Dahl M, Bergan S, Åsberg A, Christensen H (2014)
    The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
    Eur J Clin Pharmacol, 70 (6), 685-93
    DOI 10.1007/s00228-014-1656-3, PubMed 24658827

    Midtvedt K, Heldal K (2014)
    Chronic kidney disease and the aging population
    Transplantation, 97 (11), e64
    DOI 10.1097/TP.0000000000000172, PubMed 24887750

    Pihlstrøm H, Mjøen G, Dahle DO, Pilz S, Midtvedt K, März W, Abedini S, Holme I, Fellström B, Jardine A, Holdaas H (2014)
    Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients
    Transplantation, 98 (11), 1219-25
    DOI 10.1097/TP.0000000000000205, PubMed 24999963

    Robertsen I, Asberg A, Granseth T, Vethe NT, Akhlaghi F, Ghareeb M, Molden E, Reier-Nilsen M, Holdaas H, Midtvedt K (2014)
    More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients
    Transplantation, 97 (12), 1266-71
    DOI 10.1097/01.TP.0000443225.66960.7e, PubMed 24521776

    Størset E, Holford N, Hennig S, Bergmann TK, Bergan S, Bremer S, Åsberg A, Midtvedt K, Staatz CE (2014)
    Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling
    Br J Clin Pharmacol, 78 (3), 509-23
    DOI 10.1111/bcp.12361, PubMed 25279405

    Publications 2013

    Dahle DO, Midtvedt K, Hartmann A, Jenssen T, Holdaas H, Mjøen G, Leivestad T, Asberg A (2013)
    Endothelial dysfunction is associated with graft loss in renal transplant recipients
    Transplantation, 95 (5), 733-9
    DOI 10.1097/TP.0b013e31827d6312, PubMed 23364481

    Dörje C, Midtvedt K, Holdaas H, Naper C, Strøm EH, Øyen O, Leivestad T, Aronsen T, Jenssen T, Flaa-Johnsen L, Lindahl JP, Hartmann A, Reisæter AV (2013)
    Early versus late acute antibody-mediated rejection in renal transplant recipients
    Transplantation, 96 (1), 79-84
    DOI 10.1097/TP.0b013e31829434d4, PubMed 23632391

    Heldal K, Midtvedt K (2013)
    Managing transplant rejection in the elderly: the benefits of less aggressive immunosuppressive regimens
    Drugs Aging, 30 (7), 459-66
    DOI 10.1007/s40266-013-0082-z, PubMed 23609876

    Heldal K, Thorarinsdottir S, Hartmann A, Leivestad T, Reisæter AV, Foss AE, Midtvedt K (2013)
    Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study
    Transplant Res, 2 (1), 11
    DOI 10.1186/2047-1440-2-11, PubMed 23799993

    Lindahl JP, Hartmann A, Horneland R, Holdaas H, Reisæter AV, Midtvedt K, Leivestad T, Oyen O, Jenssen T (2013)
    Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease
    Diabetologia, 56 (6), 1364-71
    DOI 10.1007/s00125-013-2888-y, PubMed 23549518

    Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, Reisæter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Øvrehus M, Dale DO, Pihlstrøm H, Holme I, Dekker FW, Holdaas H (2013)
    Long-term risks for kidney donors
    Kidney Int, 86 (1), 162-7
    DOI 10.1038/ki.2013.460, PubMed 24284516

    Størset E, Holford N, Midtvedt K, Bremer S, Bergan S, Åsberg A (2013)
    Importance of hematocrit for a tacrolimus target concentration strategy
    Eur J Clin Pharmacol, 70 (1), 65-77
    DOI 10.1007/s00228-013-1584-7, PubMed 24071959

    Åsberg A, Midtvedt K, van Guilder M, Størset E, Bremer S, Bergan S, Jelliffe R, Hartmann A, Neely MN (2013)
    Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
    Transpl Int, 26 (12), 1198-207
    DOI 10.1111/tri.12194, PubMed 24118301

    Publications 2012

    Brabrand K, Midtvedt K, Günther A, Marthinsen PB, Berstad AE (2012)
    Color Doppler ultrasound-guided transducer compression of post biopsy bleeding of kidney transplants
    J Clin Ultrasound, 41 (1), 26-31
    DOI 10.1002/jcu.21983, PubMed 22927091

    Hausken J, Klingenberg O, Mørkrid L, Rollag H, Foss A, Midtvedt K (2012)
    Elevated troponin I and NT-proBNP at the time of transplantation may predict a major adverse cardiac event in the early postoperative period after renal transplantation
    Transplantation, 94 (2), e15-6
    DOI 10.1097/TP.0b013e31825b7633, PubMed 22820562

    Heldal K, Midtvedt K (2012)
    Doctor, should I remain on dialysis or accept the ECD kidney offered to me?
    Am J Kidney Dis, 59 (6), 748-50
    DOI 10.1053/j.ajkd.2012.03.002, PubMed 22613394

    Holdaas H, Midtvedt K, Åsberg A (2012)
    A drug safety evaluation of everolimus in kidney transplantation
    Expert Opin Drug Saf, 11 (6), 1013-22
    DOI 10.1517/14740338.2012.722993, PubMed 22954349

    Krämer BK, Klinger M, Vítko Š, Glyda M, Midtvedt K, Stefoni S, Citterio F, Pietruck F, Squifflet JP, Segoloni G, Krüger B, Sperschneider H, Banas B, Bäckman L, Weber M, Carmellini M, Perner F, Claesson K, Marcinkowski W, Ostrowski M, Senatorski G, Nordström J, Salmela K (2012)
    Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial
    Transplantation, 94 (5), 492-8
    DOI 10.1097/TP.0b013e31825c1d6c, PubMed 22858806

    Loftheim H, Midtvedt K, Hartmann A, Reisæter AV, Falck P, Holdaas H, Jenssen T, Reubsaet L, Asberg A (2012)
    Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients
    Transplant Res, 1 (1), 9
    DOI 10.1186/2047-1440-1-9, PubMed 23369437

    Smerud KT, Dolgos S, Olsen IC, Åsberg A, Sagedal S, Reisæter AV, Midtvedt K, Pfeffer P, Ueland T, Godang K, Bollerslev J, Hartmann A (2012)
    A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation
    Am J Transplant, 12 (12), 3316-25
    DOI 10.1111/j.1600-6143.2012.04233.x, PubMed 22946930

    Syversveen T, Midtvedt K, Berstad AE, Brabrand K, Strøm EH, Abildgaard A (2012)
    Tissue elasticity estimated by acoustic radiation force impulse quantification depends on the applied transducer force: an experimental study in kidney transplant patients
    Eur Radiol, 22 (10), 2130-7
    DOI 10.1007/s00330-012-2476-4, PubMed 22610533

    Publications 2011

    Brabrand K, Holdaas H, Gunther A, Midtvedt K (2011)
    Spontaneous regression of initially elevated peak systolic velocity in renal transplant artery
    Transpl Int, 24 (6), 555-9
    DOI 10.1111/j.1432-2277.2011.01233.x, PubMed 21332581

    Heldal K, Hartmann A, Leivestad T, Foss A, Midtvedt K (2011)
    Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium
    Nephrol Dial Transplant, 26 (8), 2706-11
    DOI 10.1093/ndt/gfq786, PubMed 21285131

    Heldal K, Hartmann A, Leivestad T, Lien B, Foss AE, Midtvedt K (2011)
    Renal transplantation is also an option for patients over 70
    Tidsskr Nor Laegeforen, 131 (20), 2004-7
    DOI 10.4045/tidsskr.10.1391, PubMed 22016126

    Holdaas H, Rostaing L, Serón D, Cole E, Chapman J, Fellstrøm B, Strom EH, Jardine A, Midtvedt K, Machein U, Ulbricht B, Karpov A, O'Connell PJ, ASCERTAIN Investigators (2011)
    Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study
    Transplantation, 92 (4), 410-8
    DOI 10.1097/TP.0b013e318224c12d, PubMed 21697773

    Midtvedt K, Holdaas H (2011)
    Belatacept: BENEFIT to the kidney?
    Am J Transplant, 11 (3), 633; author reply 634
    DOI 10.1111/j.1600-6143.2010.03411.x, PubMed 21342454

    Midtvedt K, Jenssen T, Hartmann A, Vethe NT, Bergan S, Havnes K, Åsberg A (2011)
    No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus
    Nephrol Dial Transplant, 26 (11), 3767-72
    DOI 10.1093/ndt/gfr153, PubMed 21471328

    Midtvedt K, Namtvedt T, Scott H, Abedini S, Rocke JC, Dørje C, Foss S, Christen U, Hagness M, Hartmann A (2011)
    Single transplanted kidneys from a 90-year-old deceased donor perform acceptably at 1 year
    Transplant Proc, 43 (5), 2107-9
    DOI 10.1016/j.transproceed.2011.01.192, PubMed 21693337

    Mjøen G, Oyen O, Midtvedt K, Dahle DO, Norby G, Holdaas H (2011)
    Age, gender, and body mass index are associated with renal function after kidney donation
    Clin Transplant, 25 (6), E579-83
    DOI 10.1111/j.1399-0012.2011.01503.x, PubMed 21906171

    Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2011)
    Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
    Nephrol Dial Transplant, 27 (1), 443-7
    DOI 10.1093/ndt/gfr303, PubMed 21636826

    Mjøen G, Stavem K, Westlie L, Midtvedt K, Fauchald P, Norby G, Holdaas H (2011)
    Quality of life in kidney donors
    Am J Transplant, 11 (6), 1315-9
    DOI 10.1111/j.1600-6143.2011.03517.x, PubMed 21486387

    Norby GE, Leivestad T, Mjøen G, Hartmann A, Midtvedt K, Gran JT, Holdaas H (2011)
    Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation
    Arthritis Rheum, 63 (3), 733-7
    DOI 10.1002/art.30184, PubMed 21360503

    Reisaeter AV, Foss A, Hartmann A, Leivestad T, Midtvedt K (2011)
    The kidney transplantation program in Norway since 2000
    Clin Transpl, 111-8
    PubMed 22755407

    Syversveen T, Brabrand K, Midtvedt K, Strøm EH, Hartmann A, Berstad AE (2011)
    Non-invasive assessment of renal allograft fibrosis by dynamic sonographic tissue perfusion measurement
    Acta Radiol, 52 (8), 920-6
    DOI 10.1258/ar.2011.110215, PubMed 21873503

    Syversveen T, Midtvedt K, Brabrand K, Øyen O, Foss A, Scholz T (2011)
    Prophylactic peritoneal fenestration to prevent morbidity after kidney transplantation: a randomized study
    Transplantation, 92 (2), 196-202
    DOI 10.1097/TP.0b013e318220f57b, PubMed 21597401

    Tangeraas T, Midtvedt K, Cvancarova M, Hirth A, Fredriksen PM, Tonstad S, Isaksen GA, Bjerre A (2011)
    Cardiorespiratory fitness in young adults with a history of renal transplantation in childhood
    Pediatr Nephrol, 26 (11), 2041-9
    DOI 10.1007/s00467-011-1898-6, PubMed 21541798

    Vethe NT, Midtvedt K, Asberg A, Amundsen R, Bergan S (2011)
    [Drug interactions and immunosuppression in organ transplant recipients]
    Tidsskr Nor Laegeforen, 131 (20), 2000-3
    DOI 10.4045/tidsskr.11.0138, PubMed 22016125

    Publications 2010

    Asberg A, Falck P, Undset LH, Dørje C, Holdaas H, Hartmann A, Midtvedt K (2010)
    Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot study
    Ther Drug Monit, 32 (2), 152-8
    DOI 10.1097/FTD.0b013e3181d3f822, PubMed 20216113

    Mjoen G, Midtvedt K, Holme I, Øyen O, Fauchald P, Bergrem H, Holdaas H (2010)
    One- and five-year follow-ups on blood pressure and renal function in kidney donors
    Transpl Int, 24 (1), 73-7
    DOI 10.1111/j.1432-2277.2010.01148.x, PubMed 20723180

    Myhre HA, Øyen O, Kårbø Ø, Midtvedt K (2010)
    Successful treatment of spontaneous kidney graft decapsulation 18 years after renal transplantation: a case report
    NDT Plus, 3 (1), 100-2
    DOI 10.1093/ndtplus/sfp148, PubMed 25949418

    Norby GE, Strøm EH, Midtvedt K, Hartmann A, Gilboe IM, Leivestad T, Stenstrøm J, Holdaas H (2010)
    Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study
    Ann Rheum Dis, 69 (8), 1484-7
    DOI 10.1136/ard.2009.122796, PubMed 20498208

    Strøm EH, Reinholt FP, Midtvedt K (2010)
    JC virus-associated nephropathy: lack of convincing documentation of the diagnosis
    Transpl Infect Dis, 13 (1), 93-4
    DOI 10.1111/j.1399-3062.2010.00594.x, PubMed 21299773

    Syversveen T, Brabrand K, Midtvedt K, Strøm EH, Hartmann A, Jakobsen JA, Berstad AE (2010)
    Assessment of renal allograft fibrosis by acoustic radiation force impulse quantification--a pilot study
    Transpl Int, 24 (1), 100-5
    DOI 10.1111/j.1432-2277.2010.01165.x, PubMed 20819192

    Tangeraas T, Midtvedt K, Fredriksen PM, Cvancarova M, Mørkrid L, Bjerre A (2010)
    Cardiorespiratory fitness is a marker of cardiovascular health in renal transplanted children
    Pediatr Nephrol, 25 (11), 2343-50
    DOI 10.1007/s00467-010-1596-9, PubMed 20676694

    Publications 2009

    Amundsen R, Asberg A, Robertsen I, Vethe NT, Bergan S, Hartmann A, Midtvedt K (2009)
    Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients
    Transplantation, 87 (8), 1221-4
    DOI 10.1097/TP.0b013e31819f1001, PubMed 19384170

    Asberg A, Midtvedt K, Voytovich MH, Line PD, Narverud J, Reisaeter AV, Mørkrid L, Jenssen T, Hartmann A (2009)
    Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantation
    Clin Transplant, 23 (4), 511-8
    DOI 10.1111/j.1399-0012.2009.00962.x, PubMed 19210527

    Bremer S, Vethe NT, Rootwelt H, Jørgensen PF, Stenstrøm J, Holdaas H, Midtvedt K, Bergan S (2009)
    Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study
    J Transl Med, 7, 64
    DOI 10.1186/1479-5876-7-64, PubMed 19635156

    Falck P, Midtvedt K, Vân Lê TT, Storehagen L, Holdaas H, Hartmann A, Asberg A (2009)
    A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients
    Clin Pharmacokinet, 48 (9), 615-23
    DOI 10.2165/11313380-000000000-00000, PubMed 19725595

    Foss A, Heldal K, Scott H, Foss S, Leivestad T, Jørgensen PF, Scholz T, Midtvedt K (2009)
    Kidneys from deceased donors more than 75 years perform acceptably after transplantation
    Transplantation, 87 (10), 1437-41
    DOI 10.1097/TP.0b013e3181a4ebd2, PubMed 19461478

    Heldal K, Hartmann A, Grootendorst DC, de Jager DJ, Leivestad T, Foss A, Midtvedt K (2009)
    Benefit of kidney transplantation beyond 70 years of age
    Nephrol Dial Transplant, 25 (5), 1680-7
    DOI 10.1093/ndt/gfp681, PubMed 20038521

    Heldal K, Hartmann A, Leivestad T, Svendsen MV, Foss A, Lien B, Midtvedt K (2009)
    Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity
    Transplantation, 87 (7), 1045-51
    DOI 10.1097/TP.0b013e31819cdddd, PubMed 19352126

    Midtvedt K, Bitter J, Dørje C, Bjørneklett R, Holdaas H (2009)
    Belatacept as immunosuppression in patient with recurrence of hemolytic uremic syndrome after renal transplantation
    Transplantation, 87 (12), 1901-3
    DOI 10.1097/TP.0b013e3181a991ca, PubMed 19543075

    Midtvedt K, Midtvedt T (2009)
    [Childhood diarrhea research in developing countries]
    Tidsskr Nor Laegeforen, 129 (15), 1484-5
    DOI 10.4045/tidsskr.09.0715, PubMed 19690601

    Mjøen G, Øyen O, Holdaas H, Midtvedt K, Line PD (2009)
    Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registry
    Transplantation, 88 (11), 1273-9
    DOI 10.1097/TP.0b013e3181bb44fd, PubMed 19996926

    Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J (2009)
    Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation
    Transplantation, 88 (3), 429-34
    DOI 10.1097/TP.0b013e3181af1f53, PubMed 19667949

    Witczak BJ, Leivestad T, Line PD, Holdaas H, Reisaeter AV, Jenssen TG, Midtvedt K, Bitter J, Hartmann A (2009)
    Experience from an active preemptive kidney transplantation program--809 cases revisited
    Transplantation, 88 (5), 672-7
    DOI 10.1097/TP.0b013e3181b27b7e, PubMed 19741464

    Aasebø W, Midtvedt K, Valderhaug TG, Leivestad T, Hartmann A, Reisaeter AV, Jenssen T, Holdaas H (2009)
    Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
    Nephrol Dial Transplant, 25 (4), 1289-93
    DOI 10.1093/ndt/gfp617, PubMed 19934089

    Publications 2008

    Bremer S, Mandla R, Vethe NT, Rasmussen I, Rootwelt H, Line PD, Midtvedt K, Bergan S (2008)
    Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression
    Transplantation, 85 (1), 55-61
    DOI 10.1097/01.tp.0000296854.68123.03, PubMed 18192912

    Falck P, Asberg A, Byberg KT, Bremer S, Bergan S, Reubsaet JL, Midtvedt K (2008)
    Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipients
    Transplantation, 86 (10), 1379-83
    DOI 10.1097/TP.0b013e31818aa4b6, PubMed 19034006

    Falck P, Asberg A, Guldseth H, Bremer S, Akhlaghi F, Reubsaet JL, Pfeffer P, Hartmann A, Midtvedt K (2008)
    Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients
    Transplantation, 85 (2), 179-84
    DOI 10.1097/TP.0b013e31815feede, PubMed 18212621

    Foss A, Gunther A, Line PD, Brabrand K, Holdaas H, Hartmann A, Midtvedt K (2008)
    Long-term clinical outcome of paediatric kidneys transplanted to adults
    Nephrol Dial Transplant, 23 (2), 726-9
    DOI 10.1093/ndt/gfm826, PubMed 18198285

    Gunther A, Foss A, Holdaas H, Brabrand K, Hartmann A, Line PD, Midtvedt K (2008)
    Increased peak systolic velocity in the renal artery of paediatric kidneys transplanted to adult recipients
    Nephrol Dial Transplant, 23 (12), 4041-3
    DOI 10.1093/ndt/gfn358, PubMed 18586763

    Holdaas H, Bentdal O, Pfeffer P, Mjørnstedt L, Solbu D, Midtvedt K (2008)
    Early, abrupt conversion of de novo renal transplant patients from cyclosporine to everolimus: results of a pilot study
    Clin Transplant, 22 (3), 366-71
    DOI 10.1111/j.1399-0012.2008.00795.x, PubMed 18279419

    Publications 2007

    Falck P, Guldseth H, Asberg A, Midtvedt K, Reubsaet JL (2007)
    Determination of ciclosporin A and its six main metabolites in isolated T-lymphocytes and whole blood using liquid chromatography-tandem mass spectrometry
    J Chromatogr B Analyt Technol Biomed Life Sci, 852 (1-2), 345-52
    DOI 10.1016/j.jchromb.2007.01.039, PubMed 17301005

    Falck P, Vethe NT, Asberg A, Midtvedt K, Bergan S, Reubsaet JL, Holdaas H (2007)
    Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients
    Nephrol Dial Transplant, 23 (3), 1048-53
    DOI 10.1093/ndt/gfm632, PubMed 17956893

    Foss A, Line PD, Brabrand K, Midtvedt K, Hartmann A (2007)
    A prospective study on size and function of paediatric kidneys (<10 years) transplanted to adults
    Nephrol Dial Transplant, 22 (6), 1738-42
    DOI 10.1093/ndt/gfm080, PubMed 17384415

    Heldal K, Leivestad T, Hartmann A, Svendsen MV, Lien BH, Midtvedt K (2007)
    Kidney transplantation in the elderly--the Norwegian experience
    Nephrol Dial Transplant, 23 (3), 1026-31
    DOI 10.1093/ndt/gfm719, PubMed 18079146

    Hjelmesaeth J, Hagen LT, Asberg A, Midtvedt K, Størset O, Halvorsen CE, Mørkrid L, Hartmann A, Jenssen T (2007)
    The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man
    Nephrol Dial Transplant, 22 (6), 1743-9
    DOI 10.1093/ndt/gfl820, PubMed 17299003

    Midtvedt K, Bjorang O, Letting AS (2007)
    Successful pregnancy in renal transplant recipient with previous known polyomavirus nephropathy
    Clin Transplant, 21 (4), 571-3
    DOI 10.1111/j.1399-0012.2007.00673.x, PubMed 17645722

    Publications 2006

    Asberg A, Midtvedt K, Line PD, Narverud J, Holdaas H, Jenssen T, Reisaeter AV, Johnsen LF, Fauchald P, Hartmann A (2006)
    Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients
    Transplantation, 82 (1), 62-8
    DOI 10.1097/01.tp.0000225803.04995.2b, PubMed 16861943

    Boberg KM, Foss A, Midtvedt K, Schrumpf E (2006)
    ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody
    Clin Transplant, 20 (2), 265-8
    DOI 10.1111/j.1399-0012.2005.00470.x, PubMed 16640538

    Mandla R, Midtvedt K, Line PD, Hartmann A, Bergan S (2006)
    Mycophenolic acid clinical pharmacokinetics influenced by a cyclosporine C2 based immunosuppressive regimen in renal allograft recipients
    Transpl Int, 19 (1), 44-53
    DOI 10.1111/j.1432-2277.2005.00228.x, PubMed 16359376

    Midtvedt K, Brabrand K (2006)
    [Hemodynamic renal changes in right-sided heart failure]
    Tidsskr Nor Laegeforen, 126 (10), 1356; author reply 1356
    PubMed 16691279

    Olsen GH, Andresen PA, Hilmarsen HT, Bjørang O, Scott H, Midtvedt K, Rinaldo CH (2006)
    Genetic variability in BK Virus regulatory regions in urine and kidney biopsies from renal-transplant patients
    J Med Virol, 78 (3), 384-93
    DOI 10.1002/jmv.20551, PubMed 16419108

    Oyen O, Strøm EH, Midtvedt K, Bentdal O, Hartmann A, Bergan S, Pfeffer P, Brekke IB (2006)
    Calcineurin inhibitor-free immunosuppression in renal allograft recipients with thrombotic microangiopathy/hemolytic uremic syndrome
    Am J Transplant, 6 (2), 412-8
    DOI 10.1111/j.1600-6143.2005.01184.x, PubMed 16426329

    Vethe NT, Mandla R, Line PD, Midtvedt K, Hartmann A, Bergan S (2006)
    Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment
    Scand J Clin Lab Invest, 66 (1), 31-44
    DOI 10.1080/00365510500420259, PubMed 16464785

    Publications 2005

    Büchler M, Chadban S, Cole E, Midtvedt K, Thervet E, Prestele H, Keown P (2005)
    Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases
    Nephrol Dial Transplant, 21 (1), 197-202
    DOI 10.1093/ndt/gfi113, PubMed 16204301

    Kvale EØ, Dalgaard J, Lund-Johansen F, Rollag H, Farkas L, Midtvedt K, Jahnsen FL, Brinchmann JE, Olweus J (2005)
    CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection
    Blood, 107 (5), 2022-9
    DOI 10.1182/blood-2005-05-2016, PubMed 16269620

    Midtvedt K (2005)
    [Infections in immunosuppressed children]
    Tidsskr Nor Laegeforen, 125 (13), 1884; author reply 1884
    PubMed 16012580

    Nashan B, Bock A, Bosmans JL, Budde K, Fijter H, Jaques B, Johnston A, Lück R, Midtvedt K, Pallardó LM, Ready A, Salamé E, Salizzoni M, Suarez F, Thervet E (2005)
    Use of Neoral C monitoring: a European consensus
    Transpl Int, 18 (7), 768-78
    DOI 10.1111/j.1432-2277.2005.00151.x, PubMed 15948854

    Aasebø W, Midtvedt K, Hartmann A, Stavem K (2005)
    Predictors of health-related quality of life in hypertensive recipients following renal transplantation
    Clin Transplant, 19 (6), 756-62
    DOI 10.1111/j.1399-0012.2005.00416.x, PubMed 16313321

    Publications 2004

    Hartmann A, Midtvedt K, Witczak B (2004)
    [Kidney injuries and kidney failure caused by drugs]
    Tidsskr Nor Laegeforen, 124 (21), 2765-6
    PubMed 15534671

    Midtvedt K (2004)
    Therapeutic drug monitoring of cyclosporine
    Transplant Proc, 36 (2 Suppl), 430S-433S
    DOI 10.1016/j.transproceed.2004.01.025, PubMed 15041380

    Midtvedt K, Hjelmesaeth J, Hartmann A, Lund K, Paulsen D, Egeland T, Jenssen T (2004)
    Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal
    J Am Soc Nephrol, 15 (12), 3233-9
    DOI 10.1097/01.ASN.0000145435.80005.1E, PubMed 15579527

    Publications 2003

    Mandla R, Line PD, Midtvedt K, Bergan S (2003)
    Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients
    Ther Drug Monit, 25 (3), 407-14
    DOI 10.1097/00007691-200306000-00025, PubMed 12766573

    Midtvedt K, Fauchald P, Bergan S, Høieggen A, Hallan S, Svarstad E, Bergrem H, Eriksen BO, Pfeffer PF, Dalen I, Leivestad T (2003)
    C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
    Transplantation, 76 (8), 1236-8
    DOI 10.1097/01.TP.0000085046.39523.D5, PubMed 14578761

    Midtvedt K, Fauchald P, Lien B, Hartmann A, Albrechtsen D, Bjerkely BL, Leivestad T, Brekke IB (2003)
    Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection
    Clin Transplant, 17 (1), 69-74
    DOI 10.1034/j.1399-0012.2003.02105.x, PubMed 12588325

    Sagedal S, Nordal KP, Hartmann A, Midtvedt K, Foss A, Asberg A, Degré M, Fauchald P, Rollag H (2003)
    Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study
    Nephrol Dial Transplant, 18 (9), 1899-908
    DOI 10.1093/ndt/gfg302, PubMed 12937241

    Publications 2002

    Bjorang O, Tveitan H, Midtvedt K, Broch LU, Scott H, Andresen PA (2002)
    Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient
    Nephrol Dial Transplant, 17 (11), 2023-5
    DOI 10.1093/ndt/17.11.2023, PubMed 12401867

    Cole E, Midtvedt K, Johnston A, Pattison J, O'Grady C (2002)
    Recommendations for the implementation of Neoral C-2 monitoring in clinical practice
    Transplantation, 73 (9 S), UNSP 0041-1337/02/7309-S19/0-S22

    Cole E, Midtvedt K, Johnston A, Pattison J, O'Grady C (2002)
    Recommendations for the implementation of Neoral C(2) monitoring in clinical practice
    Transplantation, 73 (9 Suppl), S19-22
    PubMed 12023609

    Hartmann A, Jenssen T, Midtvedt K, Reisaeter AV, Fauchald P, Henriksen T, Monn E, Christophersen B (2002)
    [Protein-creatinine ratio--a simple method for proteinuria assessment in clinical practice]
    Tidsskr Nor Laegeforen, 122 (22), 2180-3
    PubMed 12426892

    Heldal K, Midtvedt K (2002)
    [Licorice--not just candy]
    Tidsskr Nor Laegeforen, 122 (8), 774-6
    PubMed 12092066

    Hjelmesaeth J, Hagen M, Hartmann A, Midtvedt K, Egeland T, Jenssen T (2002)
    The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation
    Clin Transplant, 16 (6), 389-96
    DOI 10.1034/j.1399-0012.2002.02059.x, PubMed 12437616

    Hjelmesaeth J, Midtvedt K, Jenssen T, Hartmann A (2002)
    Insulin resistance after renal transplantation
    Diabetes Care, 25 (7), 1260-1261

    Midtvedt K, Hartmann A (2002)
    Response to "Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared with lisinopril"
    Transplantation, 74 (1), UNSP 0041-1337/02/7401-139/0-140

    Midtvedt K, Hartmann A (2002)
    Hypertension after kidney transplantation: are treatment guidelines emerging?
    Nephrol Dial Transplant, 17 (7), 1166-9
    DOI 10.1093/ndt/17.7.1166, PubMed 12105236

    Publications 2001

    Asberg A, Midtvedt K, Vassbotn T, Hartmann A (2001)
    Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients
    Nephrol Dial Transplant, 16 (7), 1465-70
    DOI 10.1093/ndt/16.7.1465, PubMed 11427642

    Hjelmesaeth J, Hartmann A, Midtvedt K, Aakhus S, Stenstrøm J, Mørkrid L, Egeland T, Tordarson H, Fauchald P (2001)
    Metabolic cardiovascular syndrome after renal transplantation
    Nephrol Dial Transplant, 16 (5), 1047-52
    DOI 10.1093/ndt/16.5.1047, PubMed 11328915

    Hjelmesaeth J, Midtvedt K, Jenssen T, Hartmann A (2001)
    Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy
    Diabetes Care, 24 (12), 2121-6
    DOI 10.2337/diacare.24.12.2121, PubMed 11723094

    Midtvedt K, Hartmann A, Foss A, Fauchald P, Nordal KP, Rootwelt K, Holdaas H (2001)
    Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril
    Transplantation, 72 (11), 1787-92
    DOI 10.1097/00007890-200112150-00013, PubMed 11740389

    Midtvedt K, Hartmann A, Holdaas H, Fauchald P (2001)
    Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial
    Clin Transplant, 15 (6), 426-31
    DOI 10.1034/j.1399-0012.2001.150611.x, PubMed 11737121

    Midtvedt K, Ihlen H, Hartmann A, Bryde P, Bjerkely BL, Foss A, Fauchald P, Holdaas H (2001)
    Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study
    Transplantation, 72 (1), 107-11
    DOI 10.1097/00007890-200107150-00021, PubMed 11468543

    Publications 2000

    Midtvedt K, Neumayer HH (2000)
    Management strategies for posttransplant hypertension
    Transplantation, 70 (11 Suppl), SS64-9
    PubMed 11152234

    Publications 1999

    Asberg A, Attramadal H, Midtvedt K, Sund S, Hartmann A, Berg KJ (1999)
    Gene expression of the renal endothelin system in renal transplant recipients on cyclosporine A based immunosuppression
    Transplantation, 67 (7), 1056-60
    DOI 10.1097/00007890-199904150-00020, PubMed 10221493

    Hjelmesaeth J, Midtvedt K, Aakhus S, Hartmann A (1999)
    [Cardiovascular disease after kidney transplantation]
    Tidsskr Nor Laegeforen, 119 (25), 3784-8
    PubMed 10574058

    Midtvedt K (1999)
    [Infections in renal transplant recipients in Norway]
    Tidsskr Nor Laegeforen, 119 (24), 3621-3
    PubMed 10563182

    Publications 1998

    Lehne G, Nordal KP, Midtvedt K, Goggin T, Brosstad F (1998)
    Increased potency and decreased elimination of lamifiban, a GPIIb-IIIa antagonist, in patients with severe renal dysfunction
    Thromb Haemost, 79 (6), 1119-25
    PubMed 9657435

    Midtvedt K (1998)
    [Clostridium difficile-associated diarrhea treated with homologous feces]
    Tidsskr Nor Laegeforen, 118 (11), 1758
    PubMed 9621767

    Midtvedt K, Hartmann A, Hjelmesaeth J, Lund K, Bjerkely BL (1998)
    Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients
    Nephrol Dial Transplant, 13 (2), 427-31
    DOI 10.1093/oxfordjournals.ndt.a027841, PubMed 9509457

    Midtvedt K, Hartmann A, Midtvedt T, Brekke IB (1998)
    Routine perioperative antibiotic prophylaxis in renal transplantation
    Nephrol Dial Transplant, 13 (7), 1637-41
    DOI 10.1093/ndt/13.7.1637, PubMed 9681704

    Midtvedt K, Hartmann A, Sund S (1998)
    Can a diagnosis of renal allograft rejection be based on histology alone?
    Clin Transplant, 12 (4), 300-2
    PubMed 9686323

    Publications 1997

    Midtvedt K, Hartmann A, Brekke IB, Lyngdal PT, Bentdal O, Haugen G (1997)
    Successful pregnancies in a combined pancreas and renal allograft recipient and in a renal graft recipient on tacrolimus treatment
    Nephrol Dial Transplant, 12 (12), 2764-5
    DOI 10.1093/ndt/12.12.2764, PubMed 9430893

    Publications 1996

    Midtvedt K, Hartmann A, Bentdal O, Brekke IB, Fauchald P (1996)
    Bilateral nephrectomy simultaneously with renal allografting does not alleviate hypertension 3 months following living-donor transplantation
    Nephrol Dial Transplant, 11 (10), 2045-9
    DOI 10.1093/oxfordjournals.ndt.a027094, PubMed 8918720

    Midtvedt K, Stokke ES, Hartmann A (1996)
    Successful long-term treatment of post-transplant erythrocytosis with losartan
    Nephrol Dial Transplant, 11 (12), 2495-7
    DOI 10.1093/oxfordjournals.ndt.a027224, PubMed 9017632

    Midtvedt K, Tafjord AB, Hartmann A, Eide TC, Holdaas H, Nordal KP, Draganov B, Sødal G, Leivestad T, Fauchald P (1996)
    Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection
    Transplantation, 62 (1), 38-42
    DOI 10.1097/00007890-199607150-00008, PubMed 8693541

    Publications 1994

    Gullestad L, Midtvedt K, Dolva LO, Norseth J, Kjekshus J (1994)
    The magnesium loading test: reference values in healthy subjects
    Scand J Clin Lab Invest, 54 (1), 23-31
    DOI 10.3109/00365519409086506, PubMed 8171268

    Gullestad L, Nes M, Rønneberg R, Midtvedt K, Falch D, Kjekshus J (1994)
    Magnesium status in healthy free-living elderly Norwegians
    J Am Coll Nutr, 13 (1), 45-50
    PubMed 8157853

    Publications 1993

    Midtvedt K (1993)
    [Urinary tract infections]
    Tidsskr Nor Laegeforen, 113 (5), 618-9
    PubMed 7794286

    Publications 1991

    Midtvedt K (1991)
    [Measurement of C-reactive protein gives valuable information on patients with various types of inflammation]
    Tidsskr Nor Laegeforen, 111 (13), 1660-1
    PubMed 2063373

    Midtvedt K, Myrvang B (1991)
    [Antibiotic prevention in permanent pacemaker implantation in Norway]
    Tidsskr Nor Laegeforen, 111 (9), 1106-7
    PubMed 2024255

    Publications 1990

    Madsen S, Midtvedt K (1990)
    [Penicillin in clinical use--50 years]
    Tidsskr Nor Laegeforen, 110 (30), 3884-7
    PubMed 2281453

    Publications 1985

    Midtvedt K, Midtvedt T (1985)
    Rapid determination of antibiotic susceptibility by a disc diffusion test for urgent clinical situations
    Scand J Infect Dis, 17 (1), 131-2
    DOI 10.3109/00365548509070435, PubMed 3992201

    Publications 1982

    Midtvedt T, Midtvedt K (1982)
    Sport and infection
    Scand J Soc Med Suppl, 29, 241-4
    PubMed 6958046

    MIDTVEDT T, MIDTVEDT K (1982)
    SPORT AND INFECTION
    Scand. J. Soc. Med. (29), 241-244

    Publications 1980

    Midtvedt T, Midtvedt K (1980)
    [Athletics and infections]
    Tidsskr Nor Laegeforen, 100 (12B), 859-62
    PubMed 7404535

    Page visits: 6344